Skip to main content
Kala Pharmaceuticals, Inc. (KALA)
NASDAQ: KALA · IEX Real-Time Price · USD
7.00
-0.20 (-2.78%)
At close: Apr 15, 2024, 4:00 PM
7.29
+0.29 (4.14%)
After-hours: Apr 15, 2024, 4:42 PM EDT

Kala Pharmaceuticals Market Cap

Kala Pharmaceuticals has a market cap or net worth of $19.72 million as of April 16, 2024. Its market cap has decreased by -29.59% in one year.

Market Cap
19.72M
Enterprise Value
5.14M
1-Year Change
-29.59%
Ranking
#4994
Category
Nano-Cap
Stock Price
$7.00

Market Cap Chart

Since July 20, 2017, Kala Pharmaceuticals's market cap has decreased from $430.50M to $19.72M, a decrease of -95.42%. That is a compound annual growth rate of -36.70%.

History

DateMarket Cap% Change
Apr 15, 202418.90M-2.58%
Apr 12, 202419.40M-
Apr 11, 202419.40M-2.02%
Apr 10, 202419.80M-1.00%
Apr 9, 202420.00M-2.44%
Apr 8, 202420.50M-
Apr 5, 202420.50M-1.91%
Apr 4, 202420.90M-0.48%
Apr 3, 202421.00M-2.33%
Apr 2, 202421.50M-
Apr 1, 202421.50M-
Mar 28, 202421.50M1.90%
Mar 27, 202421.10M-0.47%
Mar 26, 202421.20M-0.47%
Mar 25, 202421.30M-0.93%
Mar 22, 202421.50M-
Mar 21, 202421.50M0.47%
Mar 20, 202421.40M2.88%
Mar 19, 202420.80M0.48%
Mar 18, 202420.70M1.97%
Mar 15, 202420.30M-0.98%
Mar 14, 202420.50M-0.49%
Mar 13, 202420.60M0.98%
Mar 12, 202420.40M-3.32%
Mar 11, 202421.10M4.46%
View and export this data all the way back to 2017. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
OncoCyte 20.90M
Aptose Biosciences 20.43M
ETAO International Co. 20.28M
Streamline Health Solutions 20.00M
Lumos Pharma 19.86M
Accelerate Diagnostics 19.71M
RenovoRx 19.40M
Flora Growth 19.34M
Market Cap Rankings